IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 45.74% | 44.09% | 19.82% | 21.93% | 18.47% |
| Total Depreciation and Amortization | -5.26% | 11.33% | 70.55% | 26.76% | 20.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -701.76% | -480.73% | 4.18% | -60.72% | -42.74% |
| Change in Net Operating Assets | 197.23% | 116.40% | 10.17% | 23.29% | -41.69% |
| Cash from Operations | 35.07% | 40.42% | 24.09% | 21.99% | 13.91% |
| Capital Expenditure | 82.76% | 85.67% | 75.77% | -27.78% | 2.25% |
| Sale of Property, Plant, and Equipment | 783.33% | 1,216.67% | 1,216.67% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.63% | -51.44% | -33.19% | 2.51% | 130.84% |
| Cash from Investing | 6,725.00% | 684.91% | 413.13% | -7,300.00% | 102.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -385.67% | -883.52% | -760.17% | -503.74% | -67.50% |
| Issuance of Common Stock | -21.52% | -60.39% | -67.96% | -0.46% | -0.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -64.35% | -39.20% | -45.11% | 49.16% | 59.02% |
| Foreign Exchange rate Adjustments | -125.00% | -55.00% | 64.29% | 87.69% | 105.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.70% | 52.23% | -65.68% | 76.09% | 72.94% |